AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ONDANSETRON HYDROCHLORIDE DIHYDRATE

9 registrations across 4 African markets— 8 active

Markets with ONDANSETRON HYDROCHLORIDE DIHYDRATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
EMITINO TABLETS (Ondansetron Orally Disintegrating Tablets USP 4 mg)
Tablet Uncoated
🇿🇲ZambiaCACHET PHARMACEUTICALS PVT.LTDactiveJun 2030
ONDERON 4 MD TABLETS
Tablet
🇰🇪KenyaINNOCIA LIFESCIENCES PVT. LTDactiveDec 2027
ZOFRAN 4 mg INJECTION🇿🇦South AfricaSandoz South Africa (Pty) LtdsuspendedApr 2024
ONDANSETRON HYDROCHLORIDE DIHYDRATE
PARENTERAL ORDINARY AMPOULES
🇺🇬UgandaLEGIT MEDEQ 2007 LIMITEDactive
ONDANSETRON HYDROCHLORIDE DIHYDRATE
Parenteral Ordinary Vials
🇺🇬UgandaADWIAactive
ONDANSETRON HYDROCHLORIDE DIHYDRATE
Parenteral Ordinary Vials
🇺🇬UgandaADWIAactive
ONDANSETRON HYDROCHLORIDE DIHYDRATE
Parenteral Ordinary Vials
🇺🇬UgandaADWIAactive
ONDANSETRON HYDROCHLORIDE DIHYDRATE
Parenteral Ordinary Vials
🇺🇬UgandaADWIAactive
ONDANSETRON HYDROCHLORIDE DIHYDRATE
PARENTERAL ORDINARY AMPOULES
🇺🇬UgandaLEGIT MEDEQ 2007 LIMITEDactive

ONDANSETRON HYDROCHLORIDE DIHYDRATE in Africa — Regulatory Overview

ONDANSETRON HYDROCHLORIDE DIHYDRATE is registered across 4 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Kenya, South Africa, Zambia. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 8 (89%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.